Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
43.39
+1.34 (+3.19%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Moderna Entering Weekly Bluebox Support Area
December 17, 2023
Moderna, Inc. is an US American pharmaceutical and biotechnology company. Founded in 2010 and headquartered in Cambridge, Massachusetts, USA, it is a part of NASDAQ100 and S&P500 indices.
Via
Talk Markets
3 S&P 500 Stocks That Are About to Get Absolutely Crushed
December 16, 2023
Investors should be careful with these securities, each of which has been slumping and could fall further in the year ahead.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
December 16, 2023
The U.S. Food and Drug Administration (FDA) identified several quality control issues at the primary manufacturing facility of Moderna Inc. (NASDAQ: MRNA)
Via
Benzinga
Exposures
Product Safety
Barron's Weekend Stock Picks: Nokia, Roku, Nvidia And Moderna's Latest Cancer Treatment Trial
December 16, 2023
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
Via
Benzinga
Stock Market Rally Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review
December 15, 2023
The Dow hit a record high while the S&P 500 and Nasdaq set 2023 bests.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
2 Big Stocks Making Big Moves Thursday
December 14, 2023
One is rising while the other's on the decline. Here's why.
Via
The Motley Fool
What's Going On With Moderna (MRNA) Stock?
December 13, 2023
Moderna Inc (NASDAQ: MRNA) shares are trading lower by 4.5% to $74.50 during Wednesday's session.
Via
Benzinga
3 No-Brainer Healthcare Stocks to Buy Right Now
December 15, 2023
These players have what it takes to boost your portfolio over time.
Via
The Motley Fool
Fear & Greed Index Remains In 'Greed' Zone Following Economic Reports; Dow Records New High
December 15, 2023
The CNN Money Fear and Greed index showed some easing in overall market sentiment, but the index remained in the "Greed" zone on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Costco, Pfizer, Moderna, Lennar Corp, Tesla: Why These 5 Stocks Are On Investors' Radars Today
December 14, 2023
The stock market witnessed a notable surge today, with the Dow Jones rising 0.43% to 37,248.35 and the S&P 500 gaining 0.26% to 4,719.55.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer
December 14, 2023
Moderna is in focus after reporting positive results for its cancer treatment today, with MRNA stock surging more than 9%.
Via
InvestorPlace
Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'
December 14, 2023
Moderna, Inc. (NASDAQ: MRNA) CEO Stéphane Bancel appeared on CNBC's "Squawk Box" Thursday to discuss the company's promising new cancer vaccine developed in
Via
Benzinga
Nasdaq Turns Lower; US Retail Sales Top Estimates
December 14, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.04% to 37,105.00 while the NASDAQ fell 0.44% to 14,669.25. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday?
December 14, 2023
It’s shaping up to be a positive Thursday on Wall Street, with risk sentiment remaining robust after the Federal Reserve effectively opened the door to rate cuts in 2024.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus (RSV) Vaccine
December 14, 2023
Via
ACCESSWIRE
Why Are Bank Stocks Up Today?
December 14, 2023
Bank stocks are up today and investors wonder why have come to the right place as we have a detailed explanation for the rally!
Via
InvestorPlace
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
Jabil Posts Upbeat Earnings, Joins Moderna, Rivian Automotive And Other Big Stocks Moving Higher On Thursday
December 14, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 75 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is SOFI Stock Up Today?
December 14, 2023
SoFi Technologies stock is up on Thursday as investors celebrate news that the Federal Reserve won't increase interest rates.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Opendoor (OPEN) Stock Jumps on Analyst Upgrade
December 14, 2023
Opendoor Technologies stock is rising higher on Thursday as investors in OPEN shares react to an upgrade from Keefe, Bruyette & Woods.
Via
InvestorPlace
Why Is Moderna (MRNA) Stock Up 11% Today?
December 14, 2023
Moderna stock is on the rise Thursday as investors in MRNA react to positive results from a skin cancer vaccine in a Phase 2b trial.
Via
InvestorPlace
Moderna Stock Is Soaring Today - Here's Why
December 14, 2023
Moderna Inc (NASDAQ: MRNA) and Merck & Co Inc (NYSE: MRK) announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study of mRNA-4157 (V940), an investigational individualized...
Via
Benzinga
Moderna And Merck Announce mRNA-4157 (V940) In Combination with Keytruda(R) (Pembrolizumab) Demonstrated Continued Improvement in Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following
December 14, 2023
Via
ACCESSWIRE
Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?
December 13, 2023
Midway through the trading day on Wall Street, calm reigns supreme as investors eagerly await the Federal Reserve’s decision on interest rates.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday
December 13, 2023
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Shares of Pfizer Inc. (NYSE: PFE) shares fell sharply during Wednesday’s session after the company...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints
December 13, 2023
Pfizer's updated 2024 revenue figures, including Seagen, undercut the consensus target.
Via
Investor's Business Daily
3 Dirt-Cheap Stocks to Buy Hand Over Fist Before the End of the Year
December 13, 2023
These players could lift your portfolio when they rebound and over the long term.
Via
The Motley Fool
What's Going On With Moderna Stock Today?
December 12, 2023
Moderna Inc (NASDAQ: MRNA) announced changes to its operating model to bring focus to its short- and
Via
Benzinga
Moderna Announces Changes to Commercial Organization to Prepare for Multiple Product Launches in 2024 and 2025
December 12, 2023
Via
ACCESSWIRE
Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer
December 11, 2023
From
Merck & Co., Inc.
Via
Business Wire
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.